Menu Close

The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. 

Read all the article at the FDA website

Leave a Reply

Your email address will not be published.